Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979;7 Suppl 1(Suppl 1):83S-84S.
doi: 10.1111/j.1365-2125.1979.tb04670.x.

Differential effects of the 1,4 and 1,5 benzodiazepines on performance in healthy man

Differential effects of the 1,4 and 1,5 benzodiazepines on performance in healthy man

A N Nicholson. Br J Clin Pharmacol. 1979.

Abstract

1 The immediate and residual effects on performance of benzodiazepines differ, and the differences are important in the use of these drugs. 2. Diazepam and its hydroxylated metabolites, temazepam and oxazepam, each possess hypnotic activity, and have effects on performance limited to the sleep period. The demethylated metabolite of diazepam, nordiazepam, and its precursor, potassium clorazepate, which also possess hypnotic activity, have a longer duration of action, although the next day anxiolytic effect is accompanied by only minimal effects on performance. The 1.5 benzodiazepine, clobazam, seems to have minimal immediate effects on performance. 3 Diazepam and its hydroxylated metabolites, temazepam and oxazepam, would be useful in the management of insomnia without psychopathology in those cases in which residual effects on performance must be avoided. Nordiazepam and potassium clorazepate would be appropriate for insomnia secondary to day-time anxiety, and clobazam may be useful as a day-time anxiolytic. 4 It is emphasized that more work needs to be carried out on the effects of anxiolytics on performance before one can be certain that ingestion during the day would be without any deleterious effects on skilled work.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Clin Pharmacol. 1975 Feb;2(1):9-17 - PubMed
    1. Arzneimittelforschung. 1975 Nov;25(11):1836-9 - PubMed
    1. Br J Clin Pharmacol. 1975 Jun;2(3):215-21 - PubMed
    1. Br J Clin Pharmacol. 1977 Feb;4(1):86-9 - PubMed
    1. Br J Clin Pharmacol. 1978 Oct;6(4):325-31 - PubMed

LinkOut - more resources